Drugdiscovery >> Drugs >> News
2978
Views
Rituxan and Benlysta rated high in EU5 - drugdiscovery.com
Rituxan and Benlysta rated high in EU5 - drugdiscovery.com


Rheumatologists in the EU5 countries (France, Germany, Italy, Spain, United Kingdom) give Rituxan and Benlysta the highest satisfaction and overall product performance ratings for the treatment of moderate to severe cases of systemic lupus erythematosus (SLE).
Read More >>


Tags: rituxan, benlysta, systemic lupus erythematosus, lupus, ratings, EU5 - August 13, 2013
Related Articles
4078
Views
Rituxan: indications, interactions, side effects and warnings Rituxan: indications, interactions, side effects and warnings
Rituxan (rituximab) is a monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. It is used to treat diseases which are characterized by excessi Read More >>

Tags: Rituxan, rituximab, CD20, monoclonal antibody

4542
Views
Rituxan and Arzerra get a boxed warning of HBV risk Rituxan and Arzerra get a boxed warning of HBV risk
The anti-CD20-directed monoclonal antibodies used to treat chronic lymphocytic leukemia, rituximab (Rituxan) and ofatumumab (Arzerra), will from now carry a boxed warning of the risk for immunosuppres Read More >>

Tags: Rituxan, Arzerra, warning, HBV, risk

6114
Views
A  high blood pressure drug approved for kids too A high blood pressure drug approved for kids too
FDA has approved Silvergate Pharmaceuticals’ drug Epaned (enalapril maleate powder for oral solution) for the treatment of hypertension in patients aged one month and older. Read More >>

Tags: Epaned, hypertension, high blood pressure, children, pediatric patients

3502
Views
New Therapy  for ANCA-associated Vasculitis? New Therapy for ANCA-associated Vasculitis?
Researchers demonstrated that rituximab is as effective as cyclophosphamide - the current standard of care in patients with ANCA-associated Vasculitis, but has a shorter and simpler treatment course a Read More >>

Tags: ANCA-associated Vasculitis, Rituximab, Rituxan

2496
Views
Tamoxifen may prevent breast cancer Tamoxifen may prevent breast cancer
The results of the largest to date global study suggest that women who carry the BRCA1 or BRCA2 mutation which put them at high risk of developing breast cancer could benefit from taking tamoxifen fo Read More >>

Tags: Tamoxifen, breast cancer, prevention, BRCA 1, BRCA 2, mutation, high risk

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013